SCHEMBL24314052

SCHEMBL24314052

CC(C)C(=O)Oc1cccc(-c2ccc3c(c2)CCC(=O)N3)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 3/20 0.52
CYP11B2 P19099 3/20 0.52
CYP1A2 P05177 2/20 0.52
PDE3B Q13370 2/20 0.50
PDE3A Q14432 2/20 0.50
CYP2C9 P11712 2/20 0.50
TBXAS1 P24557 1/20 0.50
KIF11 P52732 5/20 0.47
MAPT P10636 2/20 0.42
NPC1 O15118 1/20 0.42
MMP12 P39900 1/20 0.42
RAB9A P51151 1/20 0.42
KCNH2 Q12809 1/20 0.42
CRBN Q96SW2 3/20 0.42
PKM P14618 1/20 0.42
PGR P06401 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
FABP7 O15540 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24314011 0.91 FABP7 (0.48) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL24314020 0.89 CYP11B1 (0.55) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL24314017 0.82 FABP7 (0.59) CRBNPGRFABP7FABP3FABP5
SCHEMBL24314993 0.81 CYP1A2 (0.70) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL26793073 0.79 CYP11B1 (0.50) CYP11B1CYP11B2CYP1A2CYP2C9FABP7
SCHEMBL10837629 0.77 MAOA (0.48) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL13524674 0.76 KIF11 (0.67) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL3468129 0.76 KIF11 (0.69) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL26793370 0.76 FABP7 (0.56) CYP11B1CYP11B2CYP1A2PDE3BPDE3A
SCHEMBL3309000 0.75 TDP2 (0.60) CYP11B1CYP11B2CYP1A2PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076820-A1 TRUXILLIC ACID MONOESTER-DERIVATIVES AS SELECTIVE FABP5 INHIBITORS AND PHARMACEUTICAL COMPOSITIONS AND USES THEREOF THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-04-14 WO disclosed